OpenAI and Anthropic urge Congress to regulate synthetic DNA sales as AI lowers bioweapon barriers
Posted On June 4, 2026
AI-driven regulation of synthetic DNA could reshape biotech markets, favoring larger firms and biosecurity tech, while challenging decentralized science.
The post OpenAI and Anthropic urge Congress to regulate synthetic DNA sales as AI lowers bioweapon barriers appeared first on Crypto Briefing.